These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 30205014)
1. Vitamin D potentiates anti-tumor activity of 5-fluorouracil via modulating caspase-3 and TGF-β1 expression in hepatocellular carcinoma-induced in rats. R Ebrahim A; El-Mesery M; El-Karef A; Eissa LA Can J Physiol Pharmacol; 2018 Dec; 96(12):1218-1225. PubMed ID: 30205014 [TBL] [Abstract][Full Text] [Related]
2. Allicin sensitizes hepatocellular cancer cells to anti-tumor activity of 5-fluorouracil through ROS-mediated mitochondrial pathway. Zou X; Liang J; Sun J; Hu X; Lei L; Wu D; Liu L J Pharmacol Sci; 2016 Aug; 131(4):233-40. PubMed ID: 27177453 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 enhances the tumouricidal effects of 5-Fluorouracil through multipathway mechanisms in azoxymethane rat model of colon cancer. Refaat B; El-Shemi AG; Kensara OA; Mohamed AM; Idris S; Ahmad J; Khojah A J Exp Clin Cancer Res; 2015 Jul; 34(1):71. PubMed ID: 26205949 [TBL] [Abstract][Full Text] [Related]
4. Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model. Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM Life Sci; 2019 Sep; 233():116673. PubMed ID: 31336121 [TBL] [Abstract][Full Text] [Related]
5. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Yang L; Wu D; Luo K; Wu S; Wu P Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688 [TBL] [Abstract][Full Text] [Related]
6. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma. Hu XY; Liang JY; Guo XJ; Liu L; Guo YB Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):146-53. PubMed ID: 25363523 [TBL] [Abstract][Full Text] [Related]
7. The therapeutic effects of nicotinamide in hepatocellular carcinoma through blocking IGF-1 and effecting the balance between Nrf2 and PKB. Al-Gayyar MMH; Bagalagel A; Noor AO; Almasri DM; Diri R Biomed Pharmacother; 2019 Apr; 112():108653. PubMed ID: 30784932 [TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863 [TBL] [Abstract][Full Text] [Related]
9. Chloroquine upregulates TRAIL/TRAILR2 expression and potentiates doxorubicin anti-tumor activity in thioacetamide-induced hepatocellular carcinoma model. Helmy SA; El-Mesery M; El-Karef A; Eissa LA; El Gayar AM Chem Biol Interact; 2018 Jan; 279():84-94. PubMed ID: 29133031 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of celecoxib on 5-fluorouracil-induced apoptosis in hepatocellular carcinoma patients. Bassiouny AR; Zaky A; Neenaa HM Ann Hepatol; 2010; 9(4):410-8. PubMed ID: 21057160 [TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of flavonoids from Glycyrrhiza uralensis on expressions of TGF-β1 and Caspase-3 in thioacetamide-induced hepatic fibrosis in rats]. Jing J; Zhao JY; Hua B; Xue MQ; Zhu YF; Liu G; Wang YH; Peng XD Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(15):3034-40. PubMed ID: 26677707 [TBL] [Abstract][Full Text] [Related]
13. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of the effects of PEGylated interferon-α2a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma. Motawi TK; El-Boghdady NA; El-Sayed AM; Helmy HS Tumour Biol; 2016 Feb; 37(2):1617-25. PubMed ID: 26304505 [TBL] [Abstract][Full Text] [Related]
15. The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma. Thongkum A; Wu C; Li YY; Wangpaichitr M; Navasumrit P; Parnlob V; Sricharunrat T; Bhudhisawasdi V; Ruchirawat M; Savaraj N Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587170 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of diethyl nitrosamine-induced hepatocellular carcinoma by taxifolin and/or alogliptin: The interplay between toll-like receptor 4, transforming growth factor beta-1, and apoptosis. Kabel AM; Arab HH; Abd Elmaaboud MA Hum Exp Toxicol; 2021 Oct; 40(10):1710-1720. PubMed ID: 33840231 [TBL] [Abstract][Full Text] [Related]
17. Targeting p53/TRAIL/caspase-8 signaling by adiponectin reverses thioacetamide-induced hepatocellular carcinoma in rats. Nazmy EA; El-Khouly OA; Zaki MMA; Elsherbiny NM; Said E; Al-Gayyar MMH; Salem HA Environ Toxicol Pharmacol; 2019 Nov; 72():103240. PubMed ID: 31421311 [TBL] [Abstract][Full Text] [Related]
18. Cooperative effect of Bifidobacteria lipoteichoic acid combined with 5-fluorouracil on hepatoma-22 cells growth and apoptosis. Guo B; Xie N; Wang Y Bull Cancer; 2015 Mar; 102(3):204-12. PubMed ID: 25747889 [TBL] [Abstract][Full Text] [Related]
19. Impact of Mesenchymal Stem Cells and Vitamin D on Transforming Growth Factor Beta Signaling Pathway in Hepatocellular Carcinoma in Rats. Saad El-Din S; Fouad H; Rashed LA; Mahfouz S; Hussein RE Asian Pac J Cancer Prev; 2018 Apr; 19(4):905-912. PubMed ID: 29693337 [TBL] [Abstract][Full Text] [Related]
20. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto T; Nagano H; Sakon M; Wada H; Eguchi H; Kondo M; Damdinsuren B; Ota H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Yagita H; Monden M Clin Cancer Res; 2004 Dec; 10(23):7884-95. PubMed ID: 15585621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]